Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2005-02-14 to 2005-03-02
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005
Report date:
2005

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Version / remarks:
(2001)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
Version / remarks:
(2004)
Deviations:
no
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Reference substance name:
2,4-bis[(4-aminocyclohexyl)methyl]aniline; 2,4-bis[(4-aminocyclohexyl)methyl]cyclohexan-1-amine; 2-[(1-aminocyclohexyl)methyl]aniline; 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine; 4-{[4-({4-[(4-aminocyclohexyl)methyl]cyclohexyl}amino)cyclohexyl]methyl}cyclohexan-1-amine
EC Number:
603-894-6
Cas Number:
135108-88-2
Molecular formula:
Exact identification is not feasible
IUPAC Name:
2,4-bis[(4-aminocyclohexyl)methyl]aniline; 2,4-bis[(4-aminocyclohexyl)methyl]cyclohexan-1-amine; 2-[(1-aminocyclohexyl)methyl]aniline; 4-[(4-aminocyclohexyl)methyl]cyclohexan-1-amine; 4-{[4-({4-[(4-aminocyclohexyl)methyl]cyclohexyl}amino)cyclohexyl]methyl}cyclohexan-1-amine
Test material form:
liquid: viscous
Details on test material:
Copolymer of aniline and formaldehyde, hydrogenated of Degussa AG, batch no. 923-050110 of 10 Jan. 2005.

Test animals

Species:
rat
Strain:
other: White Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ORGANISMS: 
- Source: White WISTAR, Harlan Winkelmann, Borchen, Germany
- Weight at study initiation: 165.2 - 199.0 g, about 9 weeks
- Fasting period before study: maximum 20 hours
- Diet: Altromin, rat diet, ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
- Temperature (°C): 22 °C +/- 3° C
- Humidity (%): 30 % - 70 %
- Air changes (per hr): 8 times
- Illumination: 12 hours artifical fluorescent light and 12 hours dark

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: sesame oil
Details on oral exposure:
ADMINISTRATION: 
- Frequency: single dosage on day 1
- Dose: 300 mg/kg/bw (applied as 10 % w/w) and 50 mg/kg bw (applied as 5 % w/w)
- DOSAGE PREPARATION: dispersion in sesame oil
- Starting dose 300 mg/kg bw, next step 50 mg/kg bw
Doses:
300 mg/kg/bw and 50 mg/kg bw
No. of animals per sex per dose:
3 female at 300 mg/kg
6 female at 50 mg/kg
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: periodic intervals on the dayof dosing and once daily thereafter, until day 15
- Body weight: days 1 (pre-administration) 8 and 15
- Necropsy: Animals died ahead of schedule were necropsied immediately, all survived animals were necropsied at the end of the observation period
Statistics:
no

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 50 - < 300 mg/kg bw
Mortality:
300 mg/kg: 2 of 3 female rats died within 20 minutes after application
50 mg/kg: no mortality
Clinical signs:
other: 300 mg/kg: 2 of 3 female rats showed ataxia, decreased respiration, gasping, side position and convulsion, died within 20 minutes after application 50 mg/kg: no toxic symptoms were observed
Gross pathology:
No abnormalities were found at macroscopic post mortem examination of the animals.
Other findings:
no other findings

Any other information on results incl. tables

no other information

Applicant's summary and conclusion

Conclusions:
The LD50 cut-off for VESTAMIN EP-HS 10 was estimated to be 300 mg/kg. Ranking of the test substance VESTAMIN EP-HS 10 according to the Global Harmonised System resulted in Category 3: > 50 - 300 mg/kg
Executive summary:

The acute oral toxicity study of VESTAMIN EP-HS 10 was determined with 9 female WISTAR rats. Animals were observed for symptoms of clinical toxicity and mortality for 14 days after treatment. At first 3 female rats were treated with 300 mg/kg bw. Two rats showed ataxia, decreased respiration, gasping, side position and convulsion and died within 20 minutes after application. Necropsy immediatley after the death showed no substance related morphological visible pathologic organ findings. The remaining animal showed no toxic symptoms . After that, 2 groups of 3 female rats were dosed with 50 mg/kg. No toxic symptoms were observed and no death occurred. No apparent changes were found in body weights of remaining rats. All survived animals showed

no substance related morphological visible pathologic organ findings.

The LD50 cut-off for VESTAMIN EP-HS 10 is 300 mg/kg. Ranking of the test substance VESTAMIN EP-HS 10 according to the Global Harmonised System resulted in Category 3: > 50 - 300 mg/kg